Anaesthetic management of the child with sickle cell disease

Paediatric Anaesthesia

Volumn 13, Issue 6, 2003, Pages 473-489

  Marchant, Warwick A ^a   Walker, Isabeau ^a  

^a Gt Ormond Str Hosp for Children ^*  (United Kingdom)

Author keywords

Anaemia, Sickle cell; Haemoglobin, Sickle; Paediatrics; Perioperative care

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; HEMOGLOBIN; HYDROXYUREA;

ACUTE CHEST SYNDROME; ADENOTONSILLECTOMY; ALLOIMMUNIZATION; ANEMIA; ANESTHESIA; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; BLOOD VISCOSITY; BONE DISEASE; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOMEGALY; CHILD; CHOLECYSTECTOMY; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEHYDRATION; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; HEART BLOCK; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HEART SURGERY; HEMATURIA; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; KIDNEY DISEASE; LEUKOCYTOSIS; LUNG DISEASE; NEUROLOGIC DISEASE; NEUROSURGERY; ORTHOPEDIC SURGERY; OSTEOMYELITIS; OXYGEN TENSION; PAIN; PARVOVIRUS; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PRIAPISM; PRIORITY JOURNAL; REVIEW; SCREENING; SICKLE CELL ANEMIA; SPLENECTOMY; STROKE; UMBILICAL CORD BLOOD; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE;

ANEMIA, SICKLE CELL; ANESTHESIA; CHILD; HUMANS; PERIOPERATIVE CARE;

EID: 0037826920     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01026.x     Document Type: Review

References (112)

1. Hoffbrand AV, Pettit JE. Essential Haematology, 3rd edn. Oxford, Blackwell Scientific Publications 1993.
2. Beutler E. The sickle cell diseases and related disorders. In: Beutler E, Lichtman MA, Coller BS et al., eds. Williams Hematology. New York, NY, McGraw-Hill, 1995: 616-650.
3. Rees DC, Styles L, Vichinsky EP et al. The hemoglobin E syndromes. Ann New York Ac Sci 1998; 850: 334-343.
4. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease: Rates and risk factors. NEJM 1991; 325: 11-16.
5. Serjeant GR. Sickle-cell disease. Lancet 1997; 350: 725-730.
6. World Health Organisation. Report on the VI Annual Meeting of the WHO Working Group on the Feasibility Study of Hereditary Disease Community Control Programmes (Hereditary Anaemia). Geneva: WHO, 1989 (WHO/HDP/HA/89.2).
7. Westall J. Sickle cell disease is poorly managed. BMJ 1997; 314: 396.
8. Rodgers D, Clarke J, Cupidore L. Early deaths in Jamaican children with sickle cell disease. BMJ 1978; 1: 1515-1516.
9. Schneider RG, Hosty TS, Tomlin G et al. Identification of hemoglobins and hemoglobinopathies by electrophoresis on cellulose acetate plates impregnated with citrate agar. Clin Chem 1974; 20: 74.
10. Schneider RG, Haggard ME, Gustavson LP et al. Genetic haemoglobin abnormalities in about 9,000 black and 7,000 white newborns. Br J Haematol 1974; 28: 515.
11. O'Brien RT, McIntosh S, Gregg TA et al. Prospective study of sickle cell anemia in infancy. J Ped 1976; 89: 205.
12. Reed W, Lane PA, Lorey F et al. Sickle cell disease not identified by newborn screening because of prior transfusion. J Pediatr 2000; 136: 248-250.
13. Vichinsky EP, Lubin BH. Sickle cell anemia and related hemoglobinopathies. Ped Clin N Am 1980; 27: 429-447.
14. Scott-Conner CE, Brunson CD. Pathophysiology of the sickle hemoglobinopathies and implications for perioperative management. Am J Surg 1994; 168: 268-274.
15. Davies SC, Wonke B. The management of haemoglobinopathies. Ballieres Clin Haematol 1991; 4: 361-389.
16. Vijay V, Cavenagh JD, Yate P. The anaesthetist's role in acute sickle cell crisis. Br J Anaesth 1998; 80: 820-828.
17. Tam JA, Epstein BS. Sickle cell disease and anaesthesia. Curr Prob Anesth Crit Care Med 1978; 1: 3-51.
18. Holzmann L, Finn H, Lichtman HC et al. Anesthesia in patients with sickle cell disease: a review of 112 cases. Anesth Analg 1969; 48: 566-572.
19. Noguchi CT, Schecter AN. The intracellular polymerisation of sickle hemoglobin and its relevance to sickle cell disease. Blood 1981; 58: 1057-1068.
20. Charache S, Conley CL. Rate of sickling of red cells during deoxygenation of blood from persons with various sickling disorders. Blood 1964; 24: 25-48.
21. Hebbel RP, Boogaerts MA, Eaton JW et al. Erythrocyte adherence to endothelium in sickle cell anaemia. NEJM 1980; 302: 992-995.
22. Lubin BH. Sickle cell disease and the endothelium. NEJM 1997; 337: 1623-1625.
23. Peters M, Plaat BEC, Ten Cate H et al. Enhanced thrombin generation in children with sickle cell disease. Throm Hem 1994; 71: 169-172.
24. Solovey A, Lin Y, Browne P et al. Circulating activated endothelial cells in sickle cell anemia. NEJM 1997; 337: 1584-1590.
25. Lopez R, Shimizu N, Cooperman JM. Recurrent folic acid deficiency in sickle cell disease. Am J Dis Child 1973; 125: 544-548.
26. Lawrenz DR. Sickle cell disease: a review and update of current therapy. J Oral Max Surg 1999; 57: 171-178.
27. Pearson HJ, Spencer RP, Cornelius EA. Functional asplenia in sickle cell anemia. NEJM 1969; 281: 923-936.
28. Cavenagh JD, Joseph AE, Dilly S et al. Splenic sepsis in sickle cell disease. Br J Haematol 1994; 86: 187-189.
29. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. NEJM 1994; 330: 1639-1644.
30. Sergeant GR, Chalmers RM. Is the painful crisis of sickle cell disease a 'steal' syndrome? J Clin Path 1990; 43: 789-791.
31. Griffin TC, McIntyre D, Buchanan GR. High-dose methyl-prednisolone therapy for pain in children and adolescents with sickle cell disease. NEJM 1994; 330: 733-737.
32. Ballas SK, Delengowski A. Pain measurement in hospitalised adults with sickle cell painful episodes. Ann Clin Laboratory Sci 1993; 23: 358-361.
33. Shapiro BS, Cohen DE, Howe CJ. Patient controlled analgesia for sickle related pain. J Pain Symp Manag 1993; 8: 22-28.
34. Yaster M, Tobin JR, Billett C et al. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Ped 1994; 93: 310-315.
35. Anand AJ, Glatt AE. Salmonella osteomyelitis and arthritis in sickle cell disease. Sem Arth Rheum 1994; 24: 211.
36. Vichinsky EP, Styles LA, Colangelo LH et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997; 89: 1787-1792.
37. Vichinsky EP, Williams R, Das M et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994; 83: 3107-3112.
38. Gelfand MJ, Daya SA, Rucknagel DL et al. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 1993; 34: 614-618.
39. Vichinsky EP, Neumayr LD, Earles AN et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest syndrome Study Group. NEJM 2000; 342: 1855-1865.
40. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1998; 91: 288-294.
41. Emre U, Miller ST, Rao SP et al. Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease. J Ped 1993; 123: 272-275.
42. Andrew M, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997; 87: 988-990.
43. Bernini JC, Rogers ZR, Sandler ES et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998; 92: 3082-3089.
44. Delatte SJ, Hebra A, Tagge EP et al. Acute chest syndrome in the postoperative sickle cell patient. J Ped Surg 1999; 34: 188-192.
45. Castro O, Brambilla DJ, Thorington B et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994; 84: 643-649.
46. Bowen EF, Crowston JG, De Ceulaer K et al. Peak expiratory flow rate and the acute chest syndrome in homozygous sickle cell disease. Arch Dis Child 1991; 66: 330-332.
47. Young RC, Rachal RE, Reindorf CA et al. Lung function in sickle cell hemoglobinopathy patients compared with healthy subjects. J Natl Med Assoc 1988; 80: 509-514.
48. Aquino SL, Gamsu G, Fahy JV et al. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology 1994; 193: 807-811.
49. Koumbourlis AC, Zar HJ, Hurlet-Jensen A et al. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Ped 2001; 138: 188-192.
50. Falk RH, Hood WB Jr. The heart in sickle cell anemia. Arch Int Med 1982; 142: 1680-1684.
51. Oliveira E, Gomez-Patino N. Falcemic cardiopathy: report of a case. Am J Cardiol 1963; 11: 686-688.
52. Gerry JL, Bulkley BH, Hutchins GM. Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia. Am J Cardiol 1978; 42: 211-216.
53. Seeler RA. Deaths in children with sickle cell anemia. Clin Ped 1972; 11: 634-637.
54. Cipolotti R, Costa GB, Lima WH et al. Echocardiographic characteristics of patients with sickle cell anemia in Sergipe, Brazil. J Trop Ped 2001; 47: 73-76.
55. Rees AH, Stefadouros MA, Strong WB et al. Left ventricular performance in children with homozygous sickle cell anaemia. Br Heart J 1978; 40: 690-696.
56. Val-Mejias J, Lee WK, Weisse AB et al. Left ventricular performance during and after sickle cell crisis. Am Heart J 1979; 97: 585-591.
57. Moser FG, Miller ST, Bello JA et al. The spectrum of central nervous system abnormalities in sickle cell disease as defined by magnetic resonance imaging: a report from the Cooperative Study of Sickle Cell Disease. A J N R 1996; 17: 965-972.
58. Kinney TR, Sleeper LA, Wang WA et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999; 103: 640-645.
59. Powars DR, Weiss JN, Chan LS et al. Is there a threshold of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 1984; 63: 921-926.
60. Stockman JA, Niero MA, Mishkin MM et al. Occlusion of large cerebral vessels in sickle cell anemia. NEJM 1972; 287: 846-849.
61. Adams R, McKie V, Nichols F et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. NEJM 1992; 326: 605-610.
62. Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. NEJM 1998; 339: 5-11.
63. Anson JA, Koshy M, Ferguson L et al. Subarachnoid hemorrhage in sickle-cell disease. J Neurosurg 1991; 75: 552-558.
64. Tarry WF, Duckett JW Jr, Snyder HM. Urological complications of sickle cell disease in a pediatric population. J Urol 1987; 138: 592-594.
65. Fowler JE, Koshy M, Strub M et al. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991; 145: 65-68.
66. Broderick GA, Lue TF. Priapism and the physiology of erection. AUA Update Series 1988; VII: lesson 29.
67. Miller ST, Sleeper LA, Pegelow CH et al. Prediction of adverse outcomes in children with sickle cell disease. NEJM 2000; 342: 83-89.
68. Reed W, Vichinsky EP. New considerations in the treatment of sickle cell disease. Ann Rev Med 1998; 49: 461-474.
69. Bellet P, Kalinyak K, Shukla R et al. Incentive spirometry to prevent pulmonary complications in sickle cell disease. NEJM 1995; 333: 699-702.
70. Shapiro NP, Poe MF. Sickle cell disease; an anaesthesiological problem. Anaesthesia 1955; 16: 771-780.
71. Bridenbaugh PO, Moore DC, Bridenbaugh LD. Alterations in capillary and venous blood gases after regional block anesthesia. Anesth Analg 1972; 51: 280-286.
72. Koshy M, Weiner SJ, Miller ST et al. Surgery and anesthesia in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1995; 86: 3676-3684.
73. Gross ML, Schwedler M, Bischoff RJ et al. Impact of anesthetic agents on patients with sickle cell disease. Am Surg 1993; 59: 261-264.
74. Styles LA, Vichinsky EP. New therapies and approaches to transfusion in sickle cell disease in children. Curr Op Ped 1997; 9: 41-45.
75. Davies SC. Blood transfusion in sickle cell disease. Curr Op Hematol 1996; 3: 485-491.
76. Yoto Y, Kudoh T, Haseyama K et al. Incidence of human Parvovirus B19 DNA detection in blood donors. Br J Haematol 1995; 91: 1017-1018.
77. Vichinsky EP, Earles A, Johnson RA et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. NEJM 1990; 332: 1617-1621.
78. Tahhan HR, Holbrook CT, Braddy LR et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994; 34: 562-569.
79. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Sem Hematol 2001; 38: 14-22.
80. Schmalzer EA, Lee JO, Brown AK et al. Viscosity of mixtures of sickle and normal red cells at varying haematocrit levels: implications for transfusion. Transfusion 1987; 27: 228-233.
81. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Ped Surg 1993; 28: 681-685.
82. Vichinsky EP, Haberkern CM, Neumayr L et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. NEJM 1995; 333: 206-213.
83. Adams DM, Ware RE, Schultz WH et al. Successful surgical outcome in children with sickle hemoglobinopathies: The Duke University Experience. J Ped Surg 1998; 33: 428-432.
84. Riddington C, Williamson L. Preoperative blood transfusions for sickle cell disease (Cochrane Review). In: The Cochrane Library, Issue, 3. Oxford: Update Software, 2001.
85. Ajulo SO. The significance of recurrent tonsillitis in sickle cell disease. Clin Otolaryngol 1994; 19: 230-233.
86. Davies S, Oni L. Fortnightly review. management of patients with sickle cell disease. BMJ 1997; 315: 656-660.
87. Halvorson DJ, McKie V, McKie K et al. Sickle cell disease and tonsillectomy. Arch Oto Head Neck Surg 1997; 123: 689-692.
88. Kemp JS. Obstructive sleep apnea and sickle cell disease. J Ped Hem/Onc 1996; 18: 104-105.
89. Kirkham FJ, Hewes DKM, Prengler A et al. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet 2001; 357: 1656-1659.
90. Waldron P, Pegelow C, Neumayr L et al. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. The Preoperative Transfusion in Sickle Cell Disease Study Group. J Ped Hematol/Onc 1999; 21: 129-135.
91. Brooks LJ, Koziol SM, Chiarucci KM et al. Does sleep-disordered breathing contribute to the clinical severity of sickle cell anemia? J Ped Hematol/Onc 1996; 18: 135-139.
92. Koshy M, Khakoo Y, Weiner S et al. Cooperative Study of Sickle Cell Disease Surgery Writing Committee: surgery and anesthesia in children and adults with sickle cell disease. In The National Sickle Cell Disease Program, 18th Annual Meeting, Philadelphia, PA, March 22-25, 1993: p46a.
93. Haberkern CM, Neumayr LD, Orringer EP et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Transfusion Study. The Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997; 89: 1533-1542.
94. Rutledge R, Croom RD, Davis JW Jr et al. Cholelithiasis in sickle cell anemia: surgical considerations. South Med J 1986; 79: 28-30.
95. Tagge EP, Othersen HB, Jackson SM et al. Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease. J Ped Surg 1994; 29: 209-212.
96. Ware RE, Kinney TR, Casey JR et al. Laparoscopic cholecystectomy in young patients with sickle hemoglobinopathies. J Ped 1992; 120: 58-61.
97. Hatley RM, Crist D, Howell CG et al. Laparoscopic cholecystectomy in children with sickle cell disease. Am Surg 1995; 61: 169-171.
98. Styles LA, Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle cell disease. Am J Hematol 1996; 52: 103-107.
99. Vichinsky EP, Neumayr LD, Haberkern C et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol 1999; 62: 129-138.
100. Stein RE, Urbaniak J. Use of the tourniquet during surgery in patients with sickle cell haemoglobinopathies. Clin Orth Rel Res 1980; 151: 231-233.
101. Willinsky JS, Lepow R. Sickle cell trait and the use of the pneumatic tourniquet. J Am Pod Assoc 1984; 74: 38-41.
102. Adu-Gyamfi Y, Sankarankutty M, Marwa S. Use of a tourniquet in patients with sickle cell disease. Can J An 1993; 40: 24-27.
103. Oginni LM, Rufai MB. How safe is tourniquet use in sickle-cell disease? Afr J Med Med Sci 1996; 25: 3-6.
104. Cheatham ML, Brackett CE. Problems in management of subarachnoid hemorrhage in sickle cell anemia. J Neurosurg 1965; 23: 488-493.
105. Losco P, Nash G, Stone P et al. Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S. Am J Hematol 2001; 68: 149-158.
106. Overby MC, Rothman AS. Multiple intracranial aneurysms in sickle cell anemia. Report of two cases. J Neurosurg 1985; 62: 430-434.
107. Bischoff RJ, Williamson A III, Dalali MJ et al. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies. Ann Surg 1988; 207: 434-438.
108. Bomfim V, Ribeiro A, Gouvea F et al. Sickle cell anemia and mitral valve replacement. Scand J Thor Cardiovasc Surg 1989; 23: 75-77.
109. Balasundaram S, Duran CG, Al-Halees Z et al. Cardiopulmonary bypass in sickle cell anaemia. Report of five cases. J Cardiovasc Surg 1991; 32: 271-274.
110. Madan AK, Hartz RS, Major C et al. Mitral valve replacement in sickle cell disease using intraoperative exchange transfusion. J Card Surg 1998; 13: 48-50.
111. Marchant WA, Wright S, Porter JB. Coronary artery bypass graft in a patient with haemoglobin SC disease. Anaesthesia 2001; 56: 667-669.
112. Frimpong-Boateng K, Amoah AGB, Barwasser H-M et al. Cardiopulmonary bypass in sickle cell anaemia without exchange transfusion. Eur J Cardiothor Surg 1998; 14: 527-529.